- Home
- KROS vs PBT Comparison
KROS vs PBT Comparison
Compare KROS & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- PBT
- Stock Information
- Founded
- KROS 2015
- PBT 1980
- Country
- KROS United States
- PBT United States
- Employees
- KROS N/A
- PBT N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- PBT Oil & Gas Production
- Sector
- KROS Health Care
- PBT Energy
- Exchange
- KROS Nasdaq
- PBT Nasdaq
- Market Cap
- KROS 589.8M
- PBT 558.4M
- IPO Year
- KROS 2020
- PBT N/A
- Fundamental
- Price
- KROS $11.84
- PBT $11.69
- Analyst Decision
- KROS Buy
- PBT
- Analyst Count
- KROS 11
- PBT 0
- Target Price
- KROS $45.33
- PBT N/A
- AVG Volume (30 Days)
- KROS 2.1M
- PBT 175.0K
- Earning Date
- KROS 02-26-2025
- PBT 01-01-0001
- Dividend Yield
- KROS N/A
- PBT 4.67%
- EPS Growth
- KROS N/A
- PBT 25.21
- EPS
- KROS N/A
- PBT 0.78
- Revenue
- KROS $651,000.00
- PBT $37,735,284.00
- Revenue This Year
- KROS $303.27
- PBT N/A
- Revenue Next Year
- KROS N/A
- PBT N/A
- P/E Ratio
- KROS N/A
- PBT $15.01
- Revenue Growth
- KROS 8037.50
- PBT 25.46
- 52 Week Low
- KROS $9.78
- PBT $10.14
- 52 Week High
- KROS $73.00
- PBT $15.42
- Technical
- Relative Strength Index (RSI)
- KROS 24.87
- PBT 48.90
- Support Level
- KROS $10.95
- PBT $11.51
- Resistance Level
- KROS $11.63
- PBT $12.14
- Average True Range (ATR)
- KROS 0.87
- PBT 0.41
- MACD
- KROS 1.31
- PBT 0.05
- Stochastic Oscillator
- KROS 30.60
- PBT 38.20
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.